Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants
about
MicroRNA-related genetic variations as predictors for risk of second primary tumor and/or recurrence in patients with early-stage head and neck cancerThe collagen receptor uPARAP/Endo180 in tissue degradation and cancer (Review)Second malignant neoplasms and cardiovascular disease following radiotherapy.Oral premalignancy: the roles of early detection and chemopreventionGenetic polymorphisms of p21 and risk of second primary malignancy in patients with index squamous cell carcinoma of the head and neckFAS and FASLG genetic variants and risk for second primary malignancy in patients with squamous cell carcinoma of the head and neck.Genetic variations in the regulator of G-protein signaling genes are associated with survival in late-stage non-small cell lung cancerTesticular cancer survivorship: research strategies and recommendations.Genetic variants in TGF-β pathway are associated with ovarian cancer risk.Genetic variations in regulator of G-protein signaling genes as susceptibility loci for second primary tumor/recurrence in head and neck squamous cell carcinoma.A review of cancer risk prediction models with genetic variants.A genome-wide association study of self-rated health.Transition of a clinical trial into translational research: the prostate cancer prevention trial experience.p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck.Comprehensive pathway-based interrogation of genetic variations in the nucleotide excision DNA repair pathway and risk of bladder cancer.An unusual presentation of clear cell odontogenic carcinoma in mandibular anterior region.Common genetic variants in cell cycle pathway are associated with survival in stage III-IV non-small-cell lung cancerThe Incidence Characteristics of Second Primary Malignancy after Diagnosis of Primary Colon and Rectal Cancer: A Population Based StudySite disparities in apoptotic variants as predictors of risk for second primary malignancy in patients with squamous cell carcinoma of the head and neckMiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non-Small Cell Lung CancerGenetic variants in DNA repair genes as potential predictive markers for oxaliplatin chemotherapy in colorectal cancer.Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict head and neck cancer patient second primary tumor/recurrence risk and response to retinoid chemoprevention.Association between Genetic Variants in DNA Double-Strand Break Repair Pathways and Risk of Radiation Therapy-Induced Pneumonitis and Esophagitis in Non-Small Cell Lung CancerGSTM1 copy number and promoter haplotype as predictors for risk of recurrence and/or second primary tumor in patients with head and neck cancer.MicroRNA-related genetic variants associated with clinical outcomes in early-stage non-small cell lung cancer patients.Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome.Genetic variants in p53-related genes confer susceptibility to second primary malignancy in patients with index squamous cell carcinoma of head and neck.Emerging molecular technologies for identifying the risk of second cancers.Integration of cancer genomics with treatment selection: from the genome to predictive biomarkersGenetic variations in apoptosis pathway and the risk of ovarian cancer.Global assessment of genetic variation influencing response to retinoid chemoprevention in head and neck cancer patients.Genetic variants in telomere-maintenance genes are associated with ovarian cancer risk and outcome.Genetic variants in MicroRNA biosynthesis pathways and binding sites modify ovarian cancer risk, survival, and treatment response.Genetic variations in regulator of G-protein signaling (RGS) confer risk of bladder cancerFamily history of cancer and head and neck cancer survival.Implication of stem cells in the biology and therapy of head and neck cancerGenetic variations in base excision repair pathway and risk of bladder cancer: a case-control study in the United States.
P2860
Q24629078-F1346D59-AAB5-49F3-90FD-BBFB75A687C8Q26796487-8BBF3F9E-1DF5-4638-AAEC-D5C4567AA5FDQ26864522-C4B849D0-DC05-452E-BA28-2B5C27AAE6C7Q27693327-5FAA87E8-1AE1-41D0-936A-EE93C6CA1E58Q33615319-A107FC5B-6318-4A68-A1FC-1F325721BEF8Q33903227-401728CB-6289-4831-9EBC-4351B8C43306Q33940693-545D9863-3BD0-4AAC-ACF9-281F8CD39E28Q34039684-B75608D1-887C-417C-8C0E-51BDA8ED6E68Q34044950-7DDD715F-B3A0-4CE5-B36B-9777049670BBQ34180253-40652FBC-EB2D-4DC0-9108-FC72F433D4C8Q34265269-89332ED5-93AB-446D-BC0F-3A0C3094F23CQ34585466-820DE5AA-BF44-4EB9-8C6A-1AAA9176B153Q34682926-6ED50015-76BD-4B65-8723-9CD62BADECEEQ34683811-8CF86A52-C2B0-499C-8C9B-6E266A5A3ADDQ35228293-DEF8E726-F529-4A9D-B240-8AB3C1148F4CQ35536085-9F2FF8E3-0D2A-41BD-9C3B-4224FFE4A78CQ35562928-6C37E529-6599-4336-8065-EB54E390574DQ35842157-9FBEB2A8-B480-45DA-9980-75A4D246490EQ35917835-6B48127B-69BE-4100-B7DB-C0B760C257FEQ35962631-2A845041-16B3-4073-AAC7-2BB07E0FA9A8Q36070191-94D39900-D41D-4085-8557-C6D85797CEF4Q36115675-B753A22E-FF3F-42E7-8DAA-930BD36EC6C7Q36638191-B389823D-029B-46CC-B311-E4944AB1D3BCQ36680283-7BAAE889-35C4-4FE9-A802-031F067ED48DQ36698880-5E532C3F-883C-4120-BE4D-6451CC95D18AQ36908209-868A4592-31E5-4D7B-856F-0E25500619A6Q36971948-2DFD3967-DBD0-4973-B403-17D04F61F91AQ37322288-6DA44F28-7DA7-4551-9F78-7854434E79E4Q37595614-A3491A72-644D-486D-AA59-71FC17B4566DQ37636693-D988381D-9D5A-4AD0-9C2C-D3DD09E343CAQ37638788-97633195-B42D-44E2-8605-F0A0865FD014Q37662864-0E2C31B2-E739-4155-9AF9-49C3F7BE3EE1Q37730044-F97A8689-320C-492A-86CD-B9BDDB99CAB6Q37731815-72BAD9B7-88C5-45C1-A530-329B5B65C625Q40305507-49DA34D6-1E65-4250-869C-C9AD65C6D269Q42143399-15CD0C7C-49F8-43F3-B34E-B0D1FF3E41B1Q45837886-1C9A1FEE-C0A4-4A0D-B97C-061AF36A5632
P2860
Novel susceptibility loci for second primary tumors/recurrence in head and neck cancer patients: large-scale evaluation of genetic variants
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Novel susceptibility loci for ...... evaluation of genetic variants
@ast
Novel susceptibility loci for ...... evaluation of genetic variants
@en
Novel susceptibility loci for ...... evaluation of genetic variants
@nl
type
label
Novel susceptibility loci for ...... evaluation of genetic variants
@ast
Novel susceptibility loci for ...... evaluation of genetic variants
@en
Novel susceptibility loci for ...... evaluation of genetic variants
@nl
prefLabel
Novel susceptibility loci for ...... evaluation of genetic variants
@ast
Novel susceptibility loci for ...... evaluation of genetic variants
@en
Novel susceptibility loci for ...... evaluation of genetic variants
@nl
P2093
P2860
P3181
P1476
Novel susceptibility loci for ...... evaluation of genetic variants
@en
P2093
Edward Kim
Fadlo R Khuri
Hushan Yang
J Jack Lee
Margaret R Spitz
Scott M Lippman
Waun K Hong
Yuanqing Ye
P2860
P304
P3181
P356
10.1158/1940-6207.CAPR-09-0025
P407
P50
P577
2009-07-01T00:00:00Z